Weil Company’s UnitedHealth UNH Stock Holding History

Weil Company’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-495	Closed	-$289K	–	147
2024 Q3	$289K	Buy	+495	New	+$280K	0.09%	130
2019 Q4	–	Sell	-435	Closed	-$95K	–	316
2019 Q3	$95K	Buy	+435	New	+$105K	0.07%	143

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Weil Company's UNH Position: Q4 2024 in Review

Weil Company sold out of UnitedHealth (UNH) in Q4 2024, closing a stake of 495 shares — an estimated $289K sold.

Weil Company first reported a position in UNH in Q3 2019 and held it in 2 quarters. The position peaked at $289K in Q3 2024. 3,675 funds tracked by Wall St. Rank hold UNH as of Q4 2024.

Weil Company reported no remaining UnitedHealth position as of Q4 2024 after selling out during the quarter.
Weil Company sold 495 UnitedHealth shares in Q4 2024, an estimated $289K.
Weil Company first reported a position in UnitedHealth in Q3 2019 and held it in 2 quarters.
Weil Company's UnitedHealth position peaked at $289K in Q3 2024.
3,675 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2024.

Based on Weil Company's 13F filing for Q4 2024, filed 5 Feb 2025.